1. Lipids and Lipid Derivatives for RNA Delivery
   Yuebao Zhang et al, 2021, Chemical Reviews CrossRef
2. Insights on prospects of nano-siRNA based approaches in treatment of Cancer
   Rajat Goyal et al, 2022, Frontiers in Pharmacology CrossRef
3. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme
   Marek Mazurek et al, 2020, International Journal of Molecular Sciences CrossRef
4. Small Interfering RNA Drug Delivery System in Cancer
   Prashant Nayak et al, 2024, Biomedical and Pharmacology Journal CrossRef
5. Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
   Manuela Aleku et al, 2008, Cancer Research CrossRef
6. Development of liposomal drug formulations: quality attributes and methods for quality control
   E.V. Melnikova et al, 2019, Bulletin of Russian State Medical University CrossRef
7. Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells
   Hanna Hlawaty et al, 2007, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
8. MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1
   Zhiguo Liu et al, 2014, Tumor Biology CrossRef
9. Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development
   Melissa A. Tran et al, 2008, Cancer Research CrossRef